Eagle Pharmaceuticals (EGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 103,155 | 89,681 | 108,213 | 202,016 | 109,775 |
| Receivables | 51,117 | 52,199 | 46,781 | 54,491 | 48,004 |
| Inventories | 8,075 | 6,586 | 7,891 | 8,434 | 6,566 |
| TOTAL | $166,065 | $163,796 | $168,436 | $275,572 | $179,449 |
| Non-Current Assets | |||||
| PPE Net | 2,077 | 2,123 | 2,118 | 2,423 | 2,202 |
| Intangibles | 52,660 | 53,327 | 53,993 | 54,660 | 55,326 |
| Other Non-Current Assets | 32,388 | 28,915 | 32,163 | 29,289 | 17,577 |
| TOTAL | $87,125 | $84,365 | $88,274 | $86,372 | $75,105 |
| Total Assets | $253,190 | $248,161 | $256,710 | $361,944 | $254,554 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,000 | 8,000 | 7,000 | 116,000 | 5,000 |
| Accounts payable and accrued liabilities | 6,268 | 13,068 | 13,708 | 9,756 | 5,462 |
| Accrued Expenses | 23,817 | 24,445 | 19,778 | 20,123 | N/A |
| Other current liabilities | N/A | N/A | N/A | N/A | 28,361 |
| TOTAL | $38,085 | $45,513 | $40,486 | $145,879 | $38,823 |
| Non-Current Liabilities | |||||
| Long Term Debt | 25,135 | 27,017 | 28,899 | 30,781 | 33,557 |
| Other Non-Current Liabilities | 3,959 | 2,844 | 3,361 | 3,454 | 3,000 |
| TOTAL | $29,094 | $29,861 | $32,260 | $34,235 | $36,557 |
| Total Liabilities | $67,179 | $75,374 | $72,746 | $180,114 | $75,380 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,217 | 13,030 | 13,607 | 13,685 | 13,679 |
| Common Shares | 17 | 17 | 17 | 17 | 17 |
| Retained earnings | 84,489 | 76,432 | 69,373 | 69,629 | 72,500 |
| Other shareholders' equity | 102 | 140 | 140 | 140 | 139 |
| TOTAL | $186,011 | $172,787 | $183,964 | $181,830 | $179,174 |
| Total Liabilities And Equity | $253,190 | $248,161 | $256,710 | $361,944 | $254,554 |